For the Inventor, By the Inventor

Enter assignee name

Sunnyvale, CA, United States of America

Eclipse Surgical Technologies, Inc.

USPTO Granted Patents = 67

Trademarks = 1

Forward Citations = 8,742

Loading Chart...

Loading Chart...

53 inventors (with patents filed for the assignee):

Richard L Mueller (32 out of 63 patents)

Stuart D Harman (23 out of 27 patents)

Douglas R Murphy-Chutorian (17 out of 27 patents)

4. Michael J Horzewski (8 out of 45 patents)

5. Steven A Daniel (8 out of 42 patents)

6. Jeffrey J Giba (7 out of 12 patents)

7. Michael J Rosinko (7 out of 100 patents)

8. Randy J Kesten (6 out of 62 patents)

9. Steve A Daniel (5 out of 9 patents)

10. Rick Emerson (5 out of 5 patents)

11. Richard Dean Phipps (4 out of 25 patents)

12. Alexander K Khairkhahan (4 out of 113 patents)

13. Michael Aita (4 out of 19 patents)

14. Bruce J Richardson (4 out of 60 patents)

15. Manuel Arzadon Javier, Jr (3 out of 10 patents)

Core Competencies:

Transmyocardial Revascularization

Laser Device

Drug Delivery

Minimally Invasive

Guiding Catheter

Optical Fiber

Ablation

Ultrasound Device

Heart Stabilizer

Surgical Handpiece

Therapeutic Delivery

Resistive Heating

67 patents: Sort by Forward Citations

1. 6863653 - Ultrasound device for axial ranging (2005-03-08),

2. 6482220 - Method and apparatus for creation of drug delivery and/or stimulation pockets in myocardium (2002-11-19),

3. 6391021 - Method for non-synchronous laser-assisted myocardial revascularization with stationary firing (2002-05-21),

4. 6322548 - Delivery catheter system for heart chamber (2001-11-27),

5. 6315774 - Minimally invasive apparatus for forming revascularization channels (2001-11-13),

6. 6285903 - Intracorporeal device with radiopaque marker (2001-09-04),

7. 6267757 - Revascularization with RF ablation (2001-07-31),

8. 6258083 - Viewing surgical scope for minimally invasive procedures (2001-07-10),

9. 6251104 - Guiding catheter system for ablating heart tissue (2001-06-26),

10. 6224584 - Therapeutic and diagnostic agent delivery (2001-05-01),

11. 6200311 - Minimally invasive TMR device (2001-03-13),

12. 6179809 - Drug delivery catheter with tip alignment (2001-01-30),

13. 6176856 - Resistive heating system and apparatus for improving blood flow in the heart (2001-01-23),

14. 6174307 - Viewing surgical scope for minimally invasive procedures (2001-01-16),

15. 6171251 - Method and apparatus for optimizing direct vessel implants for myocardial revascularization (2001-01-09),

Company Overview

Eclipse Surgical Technologies, Inc., based in Sunnyvale, CA, specializes in advanced medical technologies focused on myocardial revascularization. The company is known for its innovative approaches to transmyocardial revascularization, utilizing laser devices and drug delivery systems to enhance patient outcomes. Their expertise extends to minimally invasive techniques, incorporating guiding catheters, optical fibers, and ultrasound devices, aimed at improving cardiac procedures and patient care in the field of cardiovascular health.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

67 Patents

#75 in

#5,458 in

#11,031 in the World

Sunnyvale, CA, United States of America

Eclipse Surgical Technologies, Inc.

Forward Citations = 8,742

53 inventors:

Richard L Mueller (32 out of 63 patents)

Stuart D Harman (23 out of 27 patents)

Douglas R Murphy-Chutorian (17 out of 27 patents)

4. Michael J Horzewski (8 out of 45 patents)

5. Steven A Daniel (8 out of 42 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Eclipse Surgical Technologies, Inc.. Retrieved from https://idiyas.com/company/eclipse-surgical-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…